Junliang Pu - Publications, H-index & Citations

Junliang Pu

chongqing medical university

12H指数

32论文数

616被引数

收录论文 15

发表时间

Front Cover 封面

diabetes obesity metabolism

IF0

2025-09-03

OAAI

Junliang Pu PhD; Yurui Huang BS; Lei Wan MM; Mingxue Zhu MM; Huili Wei PhD; Hong Gao PhD; Liping Zhong MS; Chengyong Tang PhD; Junfang Xu PhD

First-in-human study of HDM1002, a GLP-1 receptor agonist: Safety, tolerability, pharmacokinetics and pharmacodynamics of escalating single oral doses in healthy volunteers HDM1002（一种GLP-1受体激动剂）首次人体研究：健康受试者中递增单次口服剂量的安全性、耐受性、药代动力学和药效学研究

diabetes obesity metabolism

IF0

2025-07-15

PREAI

Junliang Pu PhD; Yurui Huang BS; Lei Wan MM; Mingxue Zhu MM; Huili Wei PhD; Hong Gao PhD; Liping Zhong MS; Chengyong Tang PhD; Junfang Xu PhD

Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog®25) in Chinese healthy male volunteers 胰岛素lispro 25与原始制剂(Humalog®25)在健康中国男性志愿者中的药代动力学和药效动力学研究

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-02-25

OAAI

Zhu, Mingxue; Chen, Yuan; Wan, Lei; Li, Zhongping; Pu, Junliang; Tang, Chengyong

Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial 每周一次的新型基础胰岛素GZR4在健康参与者中的安全性，耐受性，药代动力学和药效学: 一项随机试验

DIABETES OBESITY & METABOLISM

IF5.7

2025-02-11

PREAI

Tang, Chengyong; Su, Rui; Wan, Lei; Zhu, Mingxue; Pu, Junliang; Hao, Chunyue; Zhao, Jing; He, Anshun; Xie, Tian; Li, Yue; Chen, Wei; Gan, Zhong-Ru

Study on bioequivalence and influence of obesity-related indicators on pharmacokinetics and pharmacodynamics for insulin degludec in healthy subjects 胰岛素的生物等效性及肥胖相关指标对健康受试者药代动力学和药效学影响的研究

SCIENTIFIC REPORTS

IF3.9

2024-10-21

OAAI

Su, Rui; Wan, Lei; Tao, Yi; Zhu, Mingxue; Pu, Junliang; Li, Zhongping; Chen, Yuan; Tang, Chengyong

Inhibiting TRIM8 alleviates adipocyte inflammation and insulin resistance by regulating the DUSP14/MAPKs pathway

ADIPOCYTE

IF3.1

2024-07-22

OAAI

Zhu, Mingxue; Pu, Junliang; Zhang, Ting; Shao, Huarui; Su, Rui; Tang, Chengyong

Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study 中国健康志愿者口服 (S)-奥拉西坦的安全性，耐受性和药代动力学: 一项随机，双盲，对照的I期研究

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2024-01-01

OAAI

Zhang, Ting; Tao, Yi; Pu, Junliang; Zhu, Mingxue; Wan, Lei; Tang, Chengyong

Factors Influencing Men's Attitudes toward HPV Vaccination in Males Included in the Chinese National Immunization Program

VACCINES

IF3.4

2022-06-30

OAAI

Tao, Yi; Shao, Huarui; Zhang, Ting; Pu, Junliang; Tang, Chengyong

FAM49B, restrained by miR-22, relieved hepatic ischemia/reperfusion injury by inhibiting TRAF6/IKK signaling pathway in a Rac1-dependent manner

MOLECULAR IMMUNOLOGY

IF3

2022-03-01

PREAI

Huang, Zuotian; Pu, Junliang; Luo, Yunhai; Fan, Jing; Li, Kaili; Peng, Dadi; Zong, Kezhen; Zhou, Baoyong; Guan, Xiangdong; Zhou, Fachun

Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL

IF4.4

2021-08-01

PREAI

Pu, Jun-Liang; Huang, Zuo-Tian; Luo, Yun-Hai; Mou, Tong; Li, Ting-Ting; Li, Zhong-Tang; Wei, Xu-Fu; Wu, Zhong-Jun

SET8 mitigates hepatic ischemia/reperfusion injury in mice by suppressing MARK4/NLRP3 inflammasome pathway

LIFE SCIENCES

IF5.1

2021-05-01

OAAI

Luo, Yunhai; Huang, Zuotian; Mou, Tong; Pu, Junliang; Li, Tingting; Li, Zhongtang; Yang, Hang; Yan, Ping; Wu, Zhongjun; Wu, Qiao

Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB

CELL DEATH & DISEASE

IF9.6

2020-06-12

OAAI

Huang, Zuotian; Mou, Tong; Luo, Yunhai; Pu, Xingyu; Pu, Junliang; Wan, Lei; Gong, Junhua; Yang, Hang; Liu, Yanyao; Li, Zhongtang; Shen, Ai; Wu, Zhongjun

Outcomes of adult patients adopting small-for-size grafts in living donor liver transplantation: A systematic review and meta-analysis

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL

IF4.4

2019-06-01

PREAI

Yan, Yue; Zheng, Dao-Feng; Pu, Jun-Liang; Wu, Zhong-Jun

IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway

MOLECULAR IMMUNOLOGY

IF3

2017-07-01

PREAI

Li, Ting-Ting; Zhu, Di; Mou, Tong; Guo, Zhen; Pu, Jun-Liang; Chen, Qing-Song; Wei, Xu-Fu; Wu, Zhong-Jun

Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2016-06-01

PREAI

He, Diao; Guo, Zhen; Pu, Jun-Liang; Zheng, Dao-Feng; Wei, Xu-Fu; Liu, Rui; Tang, Cheng-Yong; Wu, Zhong-Jun

研究方向